ACM  >> Vol. 10 No. 3 (March 2020)

    淋巴结转移率对不同分期胃癌患者预后影响的研究进展
    Advances in Research on thePrognosis of Gastric Cancer Patients with Lymph Node Metastasis Rate

  • 全文下载: PDF(407KB)    PP.367-372   DOI: 10.12677/ACM.2020.103058  
  • 下载量: 15  浏览量: 39  

作者:  

白 凯,李小宝:延安大学附属医院胃肠外科,陕西 延安

关键词:
胃癌淋巴结转移率预后Gastric Cancer Lymph Node Metastasis Rate Prognosis

摘要:

胃癌是最常见的肿瘤之一。影响胃癌预后的因素很多,如淋巴管侵犯、浸润深度、分化程度、肿瘤大小、淋巴结转移等。诸多研究表明淋巴结转移率是影响胃癌预后的独立因素,淋巴结转移率可更好地评价胃癌的预后,尤其对T2、T3期。现将淋巴结转移率对不同分期胃癌的预后综述如下。

Gastric cancer is one of the most common tumors. There are many factors affecting the prognosis of gastric cancer, such as lymphatic invasion, depth of invasion, degree of differentiation, tumor size, and lymph node metastasis. Many studies have shown that lymph node metastasis rate is an independent factor affecting the prognosis of gastric cancer. Lymph node metastasis rate can better evaluate the prognosis of gastric cancer, especially in T2 and T3. The prognosis of lymph node metastasis rate for different stages of gastric cancer is summarized below.

 

文章引用:
白凯, 李小宝. 淋巴结转移率对不同分期胃癌患者预后影响的研究进展[J]. 临床医学进展, 2020, 10(3): 367-372. https://doi.org/10.12677/ACM.2020.103058

参考文献

[1] Yin, J., Song, J.N., Bai, Z.G., Zhang, Z.T., et al. (2017) Gastric Cancer Mortality Trends in China (2006-2013) Reveal Increasing Mortality in Young Subjects. Anticancer Research, 37, 4671-4679.
https://doi.org/10.21873/anticanres.11871
[2] Marchet, A., Mocellin, S., Ambrosi, A., et al. (2007) The Ratio between Metastatic and Examined Lymph Nodes (N Ratio) Is an Independent Prognostic Factor in Gastric Cancer Re-gardless of the Type of Lymphadenectomy: Results from an Italian Multicentric Study in 1853 Patients. Annals of Surgery, 245, 543-552.
https://doi.org/10.1097/01.sla.0000250423.43436.e1
[3] Marchet, A.J., Mocellin, S.J., Ambrosi, A., et al. (2008) The Prognostic Value of N-Ratio in Patients with Gastric Cancer: Validation in a Large, Multicenter Series. European Journal of Surgical Oncology, 34, 159-165.
https://doi.org/10.1016/j.ejso.2007.04.018
[4] Wang, J., Dang, P., Raut, C.P.J., et al. (2012) Comparison of a Lymph Node Ratio-Based Staging System with the 7th AJCC System for Gastric Cancer: Analysis of 18,043 Patients from the SEER Database. Annals of Surgery, 255, 478-485.
https://doi.org/10.1097/SLA.0b013e31824857e2
[5] Saka, M., Katai, H., Fukagawa, T., Nijjar, R. and Sano, T. (2008) Recurrence in Early Gastric Cancer with Lymph Node Metastasis. Gastric Cancer, 11, 214-218.
https://doi.org/10.1007/s10120-008-0485-4
[6] Folli, S., Morgagni, P., Roviello, F., et al. (2001) Risk Factors for Lymph Mode Metastases and Their Prognostic Significance in Early Gastric Cancer (EGC) for the Italian Research Group for Gastric Cancer (IRGC). Journal Japanese Journal of Clinical Oncology, 31, 495-499.
https://doi.org/10.1093/jjco/hye107
[7] Ounji, Y., Suzuki, T., et al. (2003) Prognostic Significance of the Number of Metastatic Lymph Nodes in Early Gastric Cancer. Digestive Surgery, 20, 148-153.
https://doi.org/10.1159/000069392
[8] 王胤奎, 李子禹, 陕飞, 苗儒林, 薛侃, 李浙民, 高超, 陈楠, 高翔宇, 李沈, 季加孚. 我国早期胃癌的诊治现状——来自中国胃肠肿瘤外科联盟数据的启示[J]. 中华胃肠外科杂志, 2018, 21(2): 168-174.
[9] 李继坤, 延庆, 陈进. 早期胃癌淋巴结转移规律及预后分析[J]. 中国实用外科杂志, 2002, 22(5): 284-286.
[10] 沈历宗, 黄一鸣, 孙茂才, 等. 胃黏膜下层癌淋巴结转移临床病理因素分析[J]. 中国实用外科杂志, 2009, 29(1): 91-93.
[11] Tanabe, H., Washita, A., Haraoka, S., et al. (2006) Clinicopathological Characteristics of Intramucosal Gastric Carcinoma with Lymph Node Metastasis. Stomach and Intestine (Tokyo), 41, 1119-1129.
[12] Kim, D.Y., Joe, J.K., Ryu, S.Y., et al. (2004) Factors Related to Lymph Node Metastasis and Surgical Strategy Used to Treat Early Gastric Carcinoma. World Journal of Gastroenterology, 10, 737-740.
https://doi.org/10.3748/wjg.v10.i5.737
[13] Pelz, J., Merkel, S., Horbach, T., et al. (2004) Determination of Nodal Status and Treatment in Early Gastric Cancer. European Journal of Surgical Oncology, 30, 935-941.
https://doi.org/10.1016/j.ejso.2004.07.016
[14] Kunisaki, C., Shimada, H., Nomura, M., et al. (2001) Appropriate Lymphnode Dissection for Early Gastric Cancer Based on Lymph Node Metastases. Surgery, 129, 153-157.
https://doi.org/10.1067/msy.2001.110222
[15] Skoropad, V., Berdov, B. and Zagrebin, V. (2005) Clinicopathological Features and Outcome of Surgical Treatment of 149 Patients with Early (pT1) Gastric Cancer. Onkologie, 28, 247-252.
[16] Hyung, W.J., Noh, S.H., Yoo, C.H., et al. (2002) Prognostic Significance of Metastatic Lymph Node Ration in T3 Gastric Cancer. World Journal of Surgery, 26, 323-329.
https://doi.org/10.1007/s00268-001-0227-9
[17] 冯润华, 朱正纲, 燕敏, 陈军, 项明, 尹浩然, 林言箴. 淋巴结转移率对T2-T3期胃癌患者预后评估的价值[J]. 中华胃肠外科杂志, 2007, 10(5): 431-435.
[18] 任春光. 胃癌患者各pT期与阳性淋巴结转移率的预后关系[D]: [硕士学位论文]. 乌鲁木齐: 新疆医科大学, 2016.
[19] 于俊秀, 吴育连, 杨立涛. 淋巴结转移率评估T3期胃癌病人预后的价值[J]. 中华医学杂志, 2005, 85(13): 922-925.
[20] 刘晓文, 王亚农, 朱蕙燕, 等. 淋巴结转移阳性比率在预测T3期胃癌患者预后中的价值[J]. 中国癌症杂志, 2009, 19(5): 371-376.
[21] Feng, J., Wu, Y.F., Xu, H.M., et al. (2011) Prognostic Significance of the Metastatic Lymph Node Ratio in T3 Gastric Cancer Patients Undergoing Total Gastrectomy. Asian Pacific Journal of Cancer Prevention, 12, 3289-3292.
[22] 李凤科, 宋书彬, 薛英威. 淋巴结转移率在T3期胃癌预后中的临床意义(附347例) [J]. 现代肿瘤医学, 2019, 27(1): 87-91.
[23] Kilic, N., Gundogdu, S.B., Ozden, S., et al. (2018) The Prognostic Value of Different Node Staging Systems in Patients with ≤ 15 Lymph Nodes Following Surgery for Gastric Adenocarcinoma. Acta Chirurgica Belgica, 118, 1-6.
https://doi.org/10.1080/00015458.2017.1346036
[24] 陈烽, 林建清, 黄志军, 陈志耀, 叶泽毅, 王伟东. 淋巴结转移率在评估T_(4a)期胃癌患者预后的探讨[J]. 中国卫生标准管理, 2018, 9(21): 32-35.
[25] Saito, H., Fukumoto, Y., Osaki, T., et al. (2008) Prognostic Significance of the Ratio between Metastatic and Dissected Lymph Nodes (N Ratio) Inpatients with Advanced Gastric Cancer. The Journal of Surgical Oncology, 97, 132-135.
https://doi.org/10.1002/jso.20929
[26] Kunisaki, C., Shimada, H., Nomura, M., et al. (2005) Clinical Impact of Metastatic Lymph Node Ratio in Advanced Gastric Cancer. Anticancer Research, 25, 1369-1376.
[27] Bando, E., Yonemura, Y., Taniguchi, K., et al. (2002) Outcome of Ratio of Lymph Node Metastasis in Gastric Carcinoma. Annals of Surgical Oncology, 9, 775-784.
https://doi.org/10.1007/BF02574500
[28] Kodera, Y., Yamamura, Y., Shimizu, Y., et al. (1998) Lymph Node Status Assessment for Gastric Carcinoma: Is the Number of Metastatic Lymph Nodes Really Practical as a Parameter for N Categories in the TNM Classification? Tumor Node Metastasis. The Journal of Surgical Oncology, 69, 15-20.
https://doi.org/10.1002/(SICI)1096-9098(199809)69:1<15::AID-JSO4>3.0.CO;2-N
[29] 冯润华, 朱正纲, 燕敏, 等. 淋巴结转移率对T2-T3期胃癌患者预后评估的价值[J]. 中华胃肠外科杂志, 2007, 10(5): 431-435.
[30] 耿宏智, 刘兵, 徐艺可, 等. 影响进展期胃癌淋巴结转移率分期和转移数量分期的病理因素[J]. 中华胃肠外科杂志, 2013, 16(4): 358-362.
[31] Tóth, D., Bíró, A., Varga, Z., árkosy, P., et al. (2017) Comparison of Different Lymph Node Staging Systems in Prognosis of Gastric Cancer: A Bi-Institutional Study from Hungary. Chinese Journal of Cancer Research, 29, 323-333.
https://doi.org/10.21147/j.issn.1000-9604.2017.04.05
[32] Agnes, A., Biondi, A., Cananzi, F.M., Persiani, R., et al. (2019) Ratio-Based Staging Systems Are Better than the 7th and 8th Editions of the TNM in Stratifying the Prognosis of Gastric Cancer Patients: A Multicenter Retrospective Study. The Journal of Surgical Oncology, 119, 948-957.
https://doi.org/10.1002/jso.25411
[33] Sun, Z., Xu, Y., Li, D.M., et al. (2010) Log Odds of Positive Lymph Nodes: A Novel Prognostic Indicator Superior to the Number-Based and the Ratio-Based N Category for Gastric Cancer Patients with R0 Resection. Cancer, 116, 2571-2580.
https://doi.org/10.1002/cncr.24989
[34] Spolverato, G., Ejaz, A., Kim, Y., et al. (2015) Prognostic Performance of Different Lymph Node Staging Systems after Curative Intent Resection for Gastric Adenocarcinoma. Annals of Surgery, 262, 991-998.
https://doi.org/10.1097/SLA.0000000000001040
[35] 周志伟. 不同淋巴结分期方法对于胃癌预后预测能力的研究[D]: [硕士学位论文]. 合肥: 安徽医科大学, 2018: 1-49.